Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Maybe an update next week?

<< Previous

Bullboard Posts

Next >>

Comment by StevenBirchon Feb 21, 2024 10:18am

101 Views

Post# 35890773

RE:Maybe an update next week?

And if we're any closer to pre-BTD being submitted, I don't think we would get a separate NR for that.

Donein25 wrote: I seem to recall in recent years that an update comes out the end of February. if so, it will be interesting to see if any NRs have now been retreated, and if so, whether they are now CR. Successful retreatment cannot be understated in importance here; it will make Rudivar much more profitable and TLT so much more valuable!!

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario